Latest Form 4 insider transactions

NASDAQ
L Barbee Ponder Iv, General Counsel of Globalstar, Inc., sold 4,720 shares of common stock on August 11, 2026 for $83.52 per share.
NYSE
Frank Martell, Chief Executive Officer and a Director of SmartRent, Inc., purchased 100,000 shares of common stock on August 11, 2026 for $1.42 per share.
NASDAQ
Eric Andrew Clark, President & CEO and a Director of Manhattan Associates Inc, sold 3,000 shares of common stock on August 11, 2026 for $197.76 per share.
NYSE
Jesus Llorca, EVP & CFO of SEACOR Marine Holdings Inc., sold 13,259 shares of common stock on August 7, 2026.
NASDAQ
Scott J Montross, President & CEO of Northwest Pipe Co, sold 2,500 shares of common stock on August 10, 2026 for $118.74 per share.
NASDAQ
Chicago Atlantic Real Estate Finance, Inc. reported Q2 2026 results, detailing progress on its merger with Chicago Atlantic BDC, Inc. and a new financing arrangement with Koch Capital.
NASDAQ
William F Concannon, a Director of Cra International, Inc., reported multiple transactions in common stock on July 16, 2026.
NASDAQ
Paul S Lalljie, See remarks of Powerfleet, Inc., reported multiple transactions in common stock on August 11, 2026.
NASDAQ
Blake Jeffrey Grayson, Chief Financial Officer of Docusign, Inc., sold 15,000 shares of common stock on August 7, 2026 for $60.00 per share.
NASDAQ
Aaron Wilkins, CFO of Northwest Pipe Co, sold 428 shares of common stock on August 10, 2026 for $120.00 per share.
NYSE
Alexander P Scarpelli, SVP, Corp. Controller and CAO* of Regal Rexnord Corp, sold 170 shares of common stock on August 10, 2026 for $176.24 per share.
NASDAQ
Lawrence E Golub, a Director of GOLUB CAPITAL BDC, Inc., sold 1,676,387 shares of common stock on August 7, 2026 for $13.06 per share.
NASDAQ
David Golub, Chairman & CEO and a Director of GOLUB CAPITAL BDC, Inc., sold 1,676,387 shares of common stock on August 7, 2026 for $13.06 per share.
NASDAQ
Anne Mcgeorge, a Director of Dianthus Therapeutics, Inc. /DE/, sold 7,750 shares of common stock on August 10, 2026.
Goldentree Asset Management Lp and 2 others reported changes in beneficial ownership of Qvc Inc common stock on August 7, 2026.
NASDAQ
Daniel S Shugar, Chief Executive Officer and a Director of Nextracker Inc., sold 67,636 shares of common stock on August 10, 2026.
NASDAQ
Steve Sanghi, President, CEO and Chair of Bd and a Director of Microchip Technology Inc, received 4,514 shares of common stock on August 7, 2026.
NASDAQ
Joseph R Krawczyk Ii, SR. CORP VP, WW CLIENT ENGMT of Microchip Technology Inc, received 302 shares of common stock on August 7, 2026.
NYSE
Eric Friedrichsen, Chief Executive Officer and a Director of CS Disco, Inc., purchased 7,500 shares of common stock on August 10, 2026 for $4.26 per share.
NYSE
Peter C Underwood, SVP - Chief Legal Officer of Fortive Corp, sold 8,662 shares of common stock on August 10, 2026 for $61.59 per share.
NASDAQ
Mathew B Bunker, SR CORPORATE VP, OPERATIONS of Microchip Technology Inc, received 280 shares of common stock on August 7, 2026.
NYSE
Kenneth Bryan Dart, a 10% owner of Flutter Entertainment plc, purchased 332,237 shares of common stock on August 7, 2026 for $94.53 per share.
NASDAQ
James Eric Bjornholt, SENIOR CORPORATE VP AND CFO of Microchip Technology Inc, received 409 shares of common stock on August 7, 2026.
NASDAQ
Simon Read, a Director of Dianthus Therapeutics, Inc. /DE/, sold 2,777 shares of common stock on August 10, 2026.
NASDAQ
Andrew Mark Brandon-Gordon, Chief Strategy Officer and COO and a Director of New Pluto Global, Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Stephen Spinelli Jr, a Director of Planet Fitness, Inc., purchased 10,000 shares of common stock on August 10, 2026 for $49.28 per share.
NASDAQ
Glenn Sobotka, Former Officer of Astrana Health, Inc., reported a transaction in 11,793 shares of common stock on August 7, 2026.
NASDAQ
David Ferris Ellison, Chief Executive Officer and a Director of New Pluto Global, Inc., reported multiple transactions in common stock on August 7, 2026.
NASDAQ
Adam M Veness, SVP, General Counsel and Sec. of Dianthus Therapeutics, Inc. /DE/, sold 20,000 shares of common stock on August 7, 2026.
NYSE
Bob R Simpson, a Director and 10% owner of TXO Partners, L.P., purchased 250,000 shares of common stock on August 7, 2026.